Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study-Reference-Cited by-同舟云学术

Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study

Published:2019-04 Issue: Volume:274 Page:176-181
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Correll Christoph U.,Stanford Arielle D.,Claxton Amy,Du Yangchun,Weiden Peter J.

Funder

Alkermes, Inc.

Alkermes

Allergan

Angelini

Gerson Lehrman Group

IntraCellular Therapies

Janssen/J&J

LB Pharma

Lundbeck

Medavante

Medscape

Merck

Neurocrine

Otsuka

Pfizer

ROVI

Servier

Sunovion

Takeda

Teva

UpToDate

Janssen and Takeda

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference31 articles.

1. Aristada (aripiprazole lauroxil) [prescribing information]. Waltham, MA: Alkermes, Inc.; January 2018.

2. Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop;Bellack;Schizophr. Bull.,2007

3. The importance of measuring psychosocial functioning in schizophrenia;Brissos;Ann. Gen. Psychiatry,2011

4. Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia;Citrome;Int. Clin. Psychopharmacol.,2016

5. Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study;Citrome;CNS Spectr.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Lurasidone on Social Functioning in Schizophrenia;The Journal of Clinical Psychiatry;2024-01-31

2. Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM;Neuropsychiatric Disease and Treatment;2023-01

3. New Antipsychotic Medications in the Last Decade;Current Psychiatry Reports;2021-11-29

4. Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study;BMC Psychiatry;2021-10-08

5. Ameliorating schizophrenia-like symptoms in vasopressin deficient male Brattleboro rat by chronic antipsychotic treatment;European Journal of Pharmacology;2021-10